Valeant Investors Should Get Cert. In PwC Fight, Report Says
A special master recommended Monday that a New Jersey federal judge certify a class of Valeant Pharmaceuticals stockholders looking to hold PwC liable for missing "red flags" that could have caught...To view the full article, register now.
Already a subscriber? Click here to view full article